| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |